EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeit

Auto-Immune Pancreatitis with Pseudo-Tumoral Mass Induced by Pembrolizumab in a Woman suffering from Metastatic Urothelial Carcinoma: Case Report and Literature survey

G Bastens, N Bletard, G Matus, F Jehaes, O Plomteux, F Renier, R Materne, B Bastens, C Focan

Acta Gastro Enterologica Belgica · 2025

DOI: 10.51821/88.4.14217 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Acta Gastro Enterologica Belgica, 2025. Verfasst von G Bastens und 8 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology Department, CHC MontLégia, Liège, Belgium. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Autoimmune Pancreatitis, Antineoplastic Agents, Immunological, Immune Checkpoint Inhibitors. Die Arbeit wurde bisher 3-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy but may induce rare immune-related adverse events including pancreatitis (ICI-PI-), which occurs in 2–4% of cases. Such ICI-PI may necessitate treatment discontinuation. We report the rare case of a 51-year-old female with Lynch syndrome treated with pembrolizumab for metastatic urothelial carcinoma. A pancreatic mass was identified during follow-up by PET/CT. Pathology from endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) could not exclude adenocarcinoma. Surgical resection revealed pathology consistent with type II autoimmune pancreatitis (AIP) in a case which represent by definition , a type III ICI-PI. We explore diagnostic criteria focusing on clinical, serological, histological as well as medical imaging features and management

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, Monoclonal, HumanizedAutoimmune PancreatitisAntineoplastic Agents, ImmunologicalImmune Checkpoint InhibitorsPancreatic NeoplasmsCarcinoma, Transitional CellHumansFemaleMiddle AgedPositron Emission Tomography Computed TomographyEndoscopic Ultrasound-Guided Fine Needle Aspiration

Stichwörter der Autor:innen

immune checkpoint inhibitors (ICIs)pancreatitispembrolizumaburothelial carcinoma

Substanzen

pembrolizumabAntibodies, Monoclonal, HumanizedAntineoplastic Agents, ImmunologicalImmune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Gastroenterology Department, CHC MontLégia, Liège, Belgium.
  • Anatomopathology Department, CHC MontLégia, Liège, Belgium.
  • Onco-Hematology Department, CHC MontLégia, Liège, Belgium.
  • Digestive Surgery Department, CHC MontLégia, Liège, Belgium.
  • Medical Imaging Department, CHC MontLégia, Liège, Belgium.

Zitieren

APA

Bastens, G., Bletard, N., Matus, G., Jehaes, F., Plomteux, O., Renier, F., Materne, R., Bastens, B., & Focan, C. (2025). Auto-Immune Pancreatitis with Pseudo-Tumoral Mass Induced by Pembrolizumab in a Woman suffering from Metastatic Urothelial Carcinoma: Case Report and Literature survey. Acta Gastro Enterologica Belgica. https://doi.org/10.51821/88.4.14217

Vancouver

Bastens G, Bletard N, Matus G, Jehaes F, Plomteux O, Renier F, et al. Auto-Immune Pancreatitis with Pseudo-Tumoral Mass Induced by Pembrolizumab in a Woman suffering from Metastatic Urothelial Carcinoma: Case Report and Literature survey. Acta Gastro Enterologica Belgica. 2025. doi:10.51821/88.4.14217

BibTeX
@article{Bastens2025,
  author = {Bastens, G and Bletard, N and Matus, G and Jehaes, F and Plomteux, O and Renier, F and Materne, R and Bastens, B and Focan, C},
  title = {Auto-Immune Pancreatitis with Pseudo-Tumoral Mass Induced by Pembrolizumab in a Woman suffering from Metastatic Urothelial Carcinoma: Case Report and Literature survey},
  journal = {Acta Gastro Enterologica Belgica},
  year = {2025},
  doi = {10.51821/88.4.14217}
}
Kostenlos starten →